Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06140173
NA

Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction

Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand

View on ClinicalTrials.gov

Summary

Adhesive small bowel obstruction (ASBO) is a condition that is commonly found in patients with history of abdominal surgery. The management for such condition can be controversial. In terms of conservative treatment, recent studies have shown conflicting outcomes on whether water soluble contrast would provide benefit in reducing number of patients needed for surgery. In addition, there are a limited number of literature that investigates the role of low-osmolar contrast in reducing operative need in patients diagnosed with ASBO. The objective of this study is to compare the operative rate of patient diagnosed with ASBO between patients who were treated with low osmolar water soluble contrast (Iohexol) and patients who were treated traditionally.

Official title: Randomized Controlled Trial of Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2024-06

Completion Date

2025-07

Last Updated

2024-04-04

Healthy Volunteers

No

Interventions

PROCEDURE

Low osmolar contrast

100 mL of 350 mg omnipaque will be administered via nasogastric tube

PROCEDURE

Sterile water

100 mL of sterile water will be administered via nasogastric tube